Cardiac Cell Cycle Activation as a Strategy to Improve iPSC-Derived Cardiomyocyte Therapy.


Over the past 2 decades, scientists and clinicians have strived to leverage stem cell therapy as a treatment for heart failure. However, a myriad of clinical trials investigating the potential of adult stem cells to restore damaged myocardium showed inconsistent effectiveness. A subsequent paradigm shift emerged with evidence that the benefits of such… (More)
DOI: 10.1161/CIRCRESAHA.117.312287


  • Presentations referencing similar topics